Review
Authors:
- Haim GavrielHGHaim Gavriel
- Grant McArthurGrant McArthur
- Andrew SizelandASAndrew Sizeland
- Michael HendersonMHMichael Henderson
- 1 August 2011
- journal article
- review article
- Published by Wolters Kluwer Health in Melanoma Research
- Vol. 21 (4) , 257-266
Abstract
Head and neck mucosal melanoma (MM) is a rare and aggressive neoplasm, with high rates of local, regional, and distant failure. Owing to the small size of most reported series and their retrospective nature, and the lack of uniform comprehensive staging system, the effect of various treatment strategies on disease control and survival has been difficult to assess. The optimal management of head and neck MM is not well defined. Surgical treatment has being advocated as the primary treatment modality, with growing consideration for postoperative radiotherapy, as wide surgical resection in the head and neck region is often difficult. Radiotherapy is recently reported as a beneficial management modality, regardless of the fact that MM has been considered to be radioresistant. As significant morbidity is expected in high doses of radiotherapy to the head and neck region, new radiographic modalities with better precision are required. Furthermore, high-energy radiotherapy was suggested as a better therapy to mucosal MM due to the suggested biology of the tumor. The high rates of locoregional recurrence and distant metastasis also suggest that a systemic treatment is needed. Currently, there is no role for adjuvant systemic therapy for patients who have been successfully resected, but recent developments in the understanding of the biology of melanoma and, in particular, specific growth pathways holds promise for the future. We strongly recommend further evaluation of the role of chemotherapy and immunotherapy to decrease the rates of distant metastasis and improve survival.Keywords
This publication has 82 references indexed in Scilit:
- Inhibition of Mutated, Activated BRAF in Metastatic MelanomaNew England Journal of Medicine, 2010
- Improved Survival with Ipilimumab in Patients with Metastatic MelanomaNew England Journal of Medicine, 2010
- Management of mucosal melanomas of the head and neck: did we make any progress?Current Opinion in Otolaryngology & Head and Neck Surgery, 2010
- Biochemotherapy in patients with advanced head and neck mucosal melanomaHead & Neck, 2008
- Head and neck mucosal melanoma: Experience with 42 patients, with emphasis on the role of postoperative radiotherapyHead & Neck, 2008
- Mucosal melanomas of the head and neck: The Princess Margaret Hospital experienceHead & Neck, 2008
- Sentinel lymph node biopsy: a new perspective in head and neck mucosal melanoma?Melanoma Research, 2006
- Particle beam radiotherapy for head and neck tumors: Radiobiological basis and clinical experienceHead & Neck, 2006
- Characteristics of Malignant Melanoma Cells in the Treatment With Fast NeutronsPigment Cell Research, 1989
- The radiosensitivity of melanoma cells in cultureBritish Journal of Radiology, 1971